Lynch Casey

CIK 00017707832 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001770783

Recent Transactions

41 trades

Disposition to Issuer
Longboard Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2024-12-02−12,367→ 0 total
Disposition to Issuer
Longboard Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2024-12-02−12,367→ 0 total
Disposition to Issuer
Longboard Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2024-12-02−22,500→ 0 total
Disposition to Issuer
Longboard Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2024-12-02−14,428→ 0 total
Disposition to Issuer
Longboard Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2024-12-02−12,500→ 0 total
Award
Longboard Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-05-23+22,500→ 22,500 total
Award
Longboard Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-05-25+12,500→ 12,500 total
Award
Longboard Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-05-24+12,367→ 12,367 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2022-01-03+440,000→ 440,000 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2021-11-18−60,000→ 23,159 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-11-18$0.46/sh+60,000→ 109,895 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-05-10$33.75/sh−13,584→ 995,190 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-05-10$34.89/sh−9,918→ 985,272 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-05-10$35.81/sh−6,315→ 978,957 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-05-10$36.73/sh−183→ 978,774 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-03-22$35.10/sh−11,211→ 1,027,563 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-03-22$36.60/sh−400→ 1,008,774 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-03-22$35.85/sh−18,089→ 1,009,474 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-03-22$36.58/sh−300→ 1,009,174 total
Award
Longboard Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-03-11+14,428→ 14,428 total
Award
Longboard Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-03-11+12,367→ 12,367 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-03$40.84/sh−2,000→ 1,053,918 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-03$38.64/sh−1,600→ 1,056,774 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-03$43.10/sh−1,512→ 1,049,306 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-03$45.73/sh−600→ 1,038,774 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-03$37.39/sh−400→ 1,058,374 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-03$39.82/sh−856→ 1,055,918 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-03$44.22/sh−1,900→ 1,047,406 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-03$45.00/sh−8,032→ 1,039,374 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-03$41.91/sh−3,100→ 1,050,818 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-02$36.75/sh−5,071→ 1,058,774 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-02$36.02/sh−14,929→ 1,063,845 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-01$35.59/sh−3,100→ 1,090,988 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-01$38.28/sh−100→ 1,079,145 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-01$36.56/sh−7,460→ 1,083,528 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-01$39.23/sh−371→ 1,078,774 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-01$34.60/sh−4,686→ 1,094,088 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-02-01$37.68/sh−4,283→ 1,079,245 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-12-11+175,000→ 175,000 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-12-11+175,000→ 175,000 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-02-06+175,000→ 175,000 total

Companies

Recent Filings

Address

C/O CORTEXYME, INC. 269 EAST GRAND AVE.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov